118 related articles for article (PubMed ID: 22003936)
1. Comparative study of peripheral neuropathy and nerve regeneration in NOD and ICR diabetic mice.
Homs J; Ariza L; Pagès G; Verdú E; Casals L; Udina E; Chillón M; Bosch A; Navarro X
J Peripher Nerv Syst; 2011 Sep; 16(3):213-27. PubMed ID: 22003936
[TBL] [Abstract][Full Text] [Related]
2. Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNbeta in beta cells.
Serafín A; Molín J; Márquez M; Blasco E; Vidal E; Foradada L; Añor S; Rabanal RM; Fondevila D; Bosch F; Pumarola M
Muscle Nerve; 2010 May; 41(5):630-41. PubMed ID: 19918773
[TBL] [Abstract][Full Text] [Related]
3. Experimental diabetes in neonatal mice induces early peripheral sensorimotor neuropathy.
Ariza L; Pagès G; García-Lareu B; Cobianchi S; Otaegui PJ; Ruberte J; Chillón M; Navarro X; Bosch A
Neuroscience; 2014 Aug; 274():250-9. PubMed ID: 24846610
[TBL] [Abstract][Full Text] [Related]
4. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase deficiency improves Wallerian degeneration and nerve regeneration in diabetic thy1-YFP mice.
Chen YS; Chung SS; Chung SK
J Neuropathol Exp Neurol; 2010 Mar; 69(3):294-305. PubMed ID: 20142761
[TBL] [Abstract][Full Text] [Related]
6. Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation.
Dieckmann A; Kriebel M; Andriambeloson E; Ziegler D; Elmlinger M
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):132-8. PubMed ID: 22020669
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid induces nerve regeneration and increases serum and nerve contents of neural growth factor in experimental diabetic neuropathy.
Hernández-Pedro N; Ordóñez G; Ortiz-Plata A; Palencia-Hernández G; García-Ulloa AC; Flores-Estrada D; Sotelo J; Arrieta O
Transl Res; 2008 Jul; 152(1):31-7. PubMed ID: 18593635
[TBL] [Abstract][Full Text] [Related]
8. Accelerated diabetic neuropathy in axons without neurofilaments.
Zochodne DW; Sun HS; Cheng C; Eyer J
Brain; 2004 Oct; 127(Pt 10):2193-200. PubMed ID: 15289271
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
[TBL] [Abstract][Full Text] [Related]
10. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms.
Kennedy JM; Zochodne DW
Brain; 2000 Oct; 123 ( Pt 10)():2118-29. PubMed ID: 11004128
[TBL] [Abstract][Full Text] [Related]
11. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
[TBL] [Abstract][Full Text] [Related]
12. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ
FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
14. Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats.
Weis J; Dimpfel W; Schröder JM
Muscle Nerve; 1995 Feb; 18(2):175-84. PubMed ID: 7823975
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid increases tissue and plasma contents of nerve growth factor and prevents neuropathy in diabetic mice.
Arrieta O; García-Navarrete R; Zúñiga S; Ordóñez G; Ortiz A; Palencia G; Morales-Espinosa D; Hernández-Pedro N; Sotelo J
Eur J Clin Invest; 2005 Mar; 35(3):201-7. PubMed ID: 15733075
[TBL] [Abstract][Full Text] [Related]
16. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
Negi G; Kumar A; Sharma SS
Biochem Biophys Res Commun; 2010 Jan; 391(1):102-6. PubMed ID: 19900402
[TBL] [Abstract][Full Text] [Related]
17. p75 neurotrophin receptor induction and macrophage infiltration in peripheral nerve during experimental diabetic neuropathy: possible relevance on regeneration.
Conti G; Stoll G; Scarpini E; Baron PL; Bianchi R; Livraghi S; Scarlato G
Exp Neurol; 1997 Jul; 146(1):206-11. PubMed ID: 9225754
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of peripheral neuropathy in streptozotocin-induced diabetes in rats].
Cai F
Zhonghua Yi Xue Za Zhi; 1989 Feb; 69(2):86-9, 8. PubMed ID: 2527588
[TBL] [Abstract][Full Text] [Related]
19. The adjuvant effect of hypertension upon diabetic peripheral neuropathy in experimental type 2 diabetes.
De Visser A; Hemming A; Yang C; Zaver S; Dhaliwal R; Jawed Z; Toth C
Neurobiol Dis; 2014 Feb; 62():18-30. PubMed ID: 23938761
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice.
Gross V; Tank J; Partke HJ; Plehm R; Diedrich A; da Costa Goncalves AC; Luft FC; Jordan J
Auton Neurosci; 2008 Feb; 138(1-2):108-13. PubMed ID: 18166503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
